Upregulation of KSRP by miR-27b provides IFN-γ-induced post-transcriptional regulation of CX3CL1 in liver epithelial cells

por Xia, Zijie, Lu, Yajing, Li, Xiaoqing, Mao, Tiebo, Chen, Xian-Ming, Zhou, Rui
Publicado 2015

CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway

por Zhang, Xiao, Zhang, Xiaofei, Mao, Tiebo, Xu, Haiyan, Cui, Jiujie, Lin, Hechun, Wang, Liwei
Publicado 2021

A narrative review of Safety management of 1 L platinum-based chemotherapy and maintenance olaparib in BRCA mutated advanced pancreatic cancer

por Yao, Jiayu, Wang, Yongchao, Mao, Tiebo, Liang, Yiyi, Zhang, Xiao, Yang, Haiyan, Hu, Jiong, Jiao, Feng, Cui, Jiujie, Wang, Liwei
Publicado 2021

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53

por Mao, Tiebo, Zhang, Xiaofei, Xu, Haiyan, Zhang, Xiao, Ge, Weiyu, Li, Shumin, Ma, Jingyu, Yue, Ming, Xue, Shengbai, Cui, Jiujie, Wang, Liwei
Publicado 2022

Cuproptosis‐related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients

por Wang, Yanling, Ge, Weiyu, Xue, Shengbai, Cui, Jiujie, Zhang, Xiaofei, Mao, Tiebo, Xu, Haiyan, Li, Shumin, Ma, Jingyu, Yue, Ming, Shentu, Daiyuan, Wang, Liwei
Publicado 2023

Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer

por Zhang, Xiaofei, Mao, Tiebo, Xu, Haiyan, Li, Shumin, Yue, Ming, Ma, Jingyu, Yao, Jiayu, Wang, Yongchao, Zhang, Xiao, Ge, Weiyu, Wang, Yanling, Shentu, Daiyuan, Wang, Liwei
Publicado 2022

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer

por Ge, Weiyu, Yue, Ming, Wang, Yanling, Wang, Yongchao, Xue, Shengbai, Shentu, Daiyuan, Mao, Tiebo, Zhang, Xiaofei, Xu, Haiyan, Li, Shumin, Ma, Jingyu, Wang, Liwei, Cui, Jiujie
Publicado 2022

A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

por Cui, Jiujie, Yang, Haiyan, Liu, Jue, Chen, Donghui, Hu, Jiong, Zhang, Haiyan, Wang, Yu, Han, Ting, Mao, Tiebo, Jiao, Feng, Biskup, Ewelina, Pan, Yaotian, Liu, Min, Wang, Liwei
Publicado 2021

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer

por Ge, Weiyu, Shentu, Daiyuan, Wang, Yongchao, Wang, Yanling, Xue, Shengbai, Yue, Ming, Mao, Tiebo, Zhang, Xiaofei, Xu, Haiyan, Li, Shumin, Ma, Jingyu, Yao, Jiayu, Cui, Jiujie, Wang, Liwei
Publicado 2022

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma

por Xue, Shengbai, Ge, Weiyu, Wang, Kexuan, Mao, Tiebo, Zhang, Xiaofei, Xu, Haiyan, Wang, Yongchao, Yao, Jiayu, Li, Shumin, Yue, Ming, Ma, Jingyu, Wang, Yanling, Shentu, Daiyuan, Cui, Jiujie, Wang, Liwei
Publicado 2022

Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer

por Xue, Shengbai, Shen, Kangjie, Wang, Kexuan, Ge, Weiyu, Mao, Tiebo, Li, Shumin, Zhang, Xiaofei, Xu, Haiyan, Wang, Yongchao, Yao, Jiayu, Yue, Ming, Ma, Jingyu, Wang, Yanling, Shentu, Daiyuan, Cui, Jiujie, Wang, Liwei
Publicado 2022

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer

por Ge, Weiyu, Ma, Jingyu, Mao, Tiebo, Xu, Haiyan, Zhang, Xiaofei, Li, Shumin, Wang, Yongchao, Yao, Jiayu, Yue, Ming, Jiao, Feng, Wang, Yu, Zhuo, Meng, Han, Ting, Hu, Jiong, Zhang, Xiao, Cui, Jiujie, Wang, Liwei
Publicado 2022

Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response

por Wang, Yu, Liang, Yiyi, Xu, Haiyan, Zhang, Xiao, Mao, Tiebo, Cui, Jiujie, Yao, Jiayu, Wang, Yongchao, Jiao, Feng, Xiao, Xiuying, Hu, Jiong, Xia, Qing, Zhang, Xiaofei, Wang, Xujun, Sun, Yongwei, Fu, Deliang, Shen, Lei, Xu, Xiaojiang, Xue, Jing, Wang, Liwei
Publicado 2021

Characterization of DNA damage response deficiency in pancreatic cancer patients from China

por Zhang, Xiaofei, Mao, Tiebo, Zhang, Bei, Xu, Haiyan, Cui, Jiujie, Jiao, Feng, Chen, Dongqin, Wang, Yu, Hu, Jiong, Xia, Qing, Li, Shumin, Yue, Ming, Ma, Jingyu, Yao, Jiayu, Wang, Yongchao, Zhang, Xiao, Chen, Shiqing, Bai, Yuezong, Wang, Yuexiang, Zhang, Xuebin, Liu, Qiang, Sun, Yongwei, Fu, Deliang, Liu, Yingbin, Xiong, Lei, Wang, Liwei
Publicado 2021

Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer

por Zhang, Xiaofei, Mao, Tiebo, Zhang, Bei, Xu, Haiyan, Cui, Jiujie, Jiao, Feng, Chen, Dongqin, Wang, Yu, Hu, Jiong, Xia, Qing, Ge, Weiyu, Li, Shumin, Yue, Ming, Ma, Jingyu, Yao, Jiayu, Wang, Yongchao, Wang, Yanling, Shentu, Daiyuan, Zhang, Xiao, Chen, Shiqing, Bai, Yuezong, Wang, Yuexiang, Zhang, Xuebin, Liu, Qiang, Sun, Yongwei, Fu, Deliang, Liu, Yingbin, Xiong, Lei, Wang, Liwei
Publicado 2022